Invesco Dorsey Wright Healthcare Momentum ETF (PTH)
| Assets | $128.65M |
| Expense Ratio | 0.60% |
| PE Ratio | 26.92 |
| Shares Out | 2.40M |
| Dividend (ttm) | $1.53 |
| Dividend Yield | 3.02% |
| Ex-Dividend Date | Dec 22, 2025 |
| Payout Ratio | 78.84% |
| 1-Year Return | +29.84% |
| Volume | 8,814 |
| Open | 51.38 |
| Previous Close | 52.10 |
| Day's Range | 50.48 - 51.38 |
| 52-Week Low | 35.78 |
| 52-Week High | 54.48 |
| Beta | 0.87 |
| Holdings | 61 |
| Inception Date | Oct 12, 2006 |
About PTH
Fund Home PageThe Invesco Dorsey Wright Healthcare Momentum ETF (PTH) is an exchange-traded fund that mostly invests in health care equity. The fund tracks an index of U.S. healthcare firms selected and weighted by price momentum. PTH was launched on Oct 12, 2006 and is issued by Invesco.
Top 10 Holdings
32.90% of assets| Name | Symbol | Weight |
|---|---|---|
| Praxis Precision Medicines, Inc. | PRAX | 5.28% |
| Roivant Sciences Ltd. | ROIV | 4.29% |
| Erasca, Inc. | ERAS | 3.31% |
| United Therapeutics Corporation | UTHR | 3.27% |
| Tango Therapeutics, Inc. | TNGX | 3.26% |
| Tenet Healthcare Corporation | THC | 2.98% |
| Terns Pharmaceuticals, Inc. | TERN | 2.75% |
| Nektar Therapeutics | NKTR | 2.67% |
| HCA Healthcare, Inc. | HCA | 2.66% |
| Celcuity Inc. | CELC | 2.42% |
Dividends
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Dec 22, 2025 | $1.52645 | Dec 26, 2025 |
| Jun 24, 2024 | $0.02545 | Jun 28, 2024 |
| Dec 20, 2013 | $0.01137 | Dec 31, 2013 |
| Sep 20, 2013 | $0.00256 | Sep 30, 2013 |
| Jun 21, 2013 | $0.03682 | Jun 28, 2013 |
| Dec 21, 2012 | $0.10903 | Dec 31, 2012 |
News
Hims & Hers, Eli Lilly, Novo Nordisk Face FDA Scrutiny: What It Means For Weight-Loss ETFs
The U.S. Food and Drug Administration's recent enforcement action against drug promotion is sending ETFs with exposure to weight-loss treatment manufacturers into question.
Best Growth ETFs for Q2 2021
The best growth ETFs for Q2 2021 are OGIG, PTF, and PTH.
Best Healthcare ETFs for Q1 2021
The best healthcare ETFs for Q1 2021 are ARKG, PTH, and KURE.
3 Health Care ETFs Where Components Are Enduring Downgrades
After setting scintillating paces earlier this thanks to the race to develop a coronavirus vaccine, some health care exchange-traded funds are languishing.
3 ETFs To Play Gilead's $21B Immunomedics Takeover
Biotechnology mergers and acquisitions appear to be back in a big way with news that Gilead Sciences (NASDAQ: GILD) is acquiring Immunomedics (NASDAQ: IMMU) for $21 billion.
Specialty biotech funds jump on promising coronavirus, funding news
Specialized health-care exchange-traded funds outperformed the broader stock market Wednesday even as stocks rebounded from a sell-off that left the Nasdaq Composite Index in correction territory. Th...
3 ETFs in Focus as Race for Vaccine Intensifies
Several companies sit at the forefront of developing a coronavirus vaccine. Gain exposure to each using the following three ETFs.